Two healthcare companies, CCS and SweetSpot, have formed a strategic alliance to deliver remote diabetes management to patients in select U.S. markets. The partnership launches a pilot program in early 2026 targeting endocrinology clinics, aiming to bridge the gap in care between office visits. With diabetes affecting more than 40 million Americans, this initiative seeks to improve outcomes through continuous monitoring and virtual support.
Filling the Void in Chronic Disease Management
Diabetes demands ongoing attention, yet most clinics struggle to track patients remotely. Tony Vahedian, CEO of CCS, a provider of clinical solutions and home-delivered supplies for chronic conditions, highlights this challenge: “Diabetes care doesn’t stop when patients leave the clinic, but most practices lack the tools and bandwidth to proactively monitor who needs help and take action between in-office visits.” CCS brings established relationships with providers and a chronic care ecosystem, positioning it to integrate new technologies effectively.
SweetSpot complements this with its remote monitoring platform, which reviews continuous glucose data and deploys Certified Diabetes Care and Education Specialists. These experts act as an extension of clinic staff, offering personalized feedback and education. The combination addresses a core issue in diabetes management: poor adherence and undetected fluctuations in blood sugar that lead to complications like neuropathy or cardiovascular disease.
How the Pilot Integrates into Clinical Workflows
The program embeds SweetSpot’s tools directly into providers’ routines, enabling real-time data insights without overwhelming staff. Patients receive virtual support between appointments, helping them maintain control over their condition. Stephen Von Rump, CEO of SweetSpot, explains the value: “SweetSpot empowers providers to give patients better care and continuous support in a scalable way. Partnering with CCS allows us to deliver even greater impact and address one of the biggest gaps in chronic disease management: what happens between appointments.”
This approach builds on the shift toward value-based care, where reimbursements increasingly reward outcomes over volume of visits. By identifying issues early, the pilot could reduce emergency interventions and hospitalizations, common burdens for diabetes patients.
Broad Implications for U.S. Healthcare
CCS’s move marks its transition from supplier to comprehensive chronic care partner, reflecting industry trends toward integrated services. The pilot’s focus on endocrinology clinics tests scalability before wider rollout, potentially influencing how other chronic conditions like hypertension are handled remotely. As diabetes prevalence rises—driven by aging populations and lifestyle factors—this model offers a practical path to extend clinic reach, easing pressure on overburdened systems while empowering patients with proactive tools.
